Literature DB >> 9101537

Gender and diurnal effects on specific open-field behavioral patterns in the portacaval shunted rat.

B Theander1, G Apelqvist, M Bugge, G Andersson, B Hindfelt, F Bengtsson.   

Abstract

Hepatic encephalopathy (HE) is a frequently observed neuropsychiatric syndrome with unknown pathogenesis in patients suffering from chronic liver failure. The portacaval shunted (PCS) rat has been extensively used as an experimental model for HE and for studying the effects of portal-systemic shunting. Previous behavioral studies on PCS rats have shown a number of abnormalities but there is no consensus about which abnormalities are characteristic. We therefore made a thorough descriptive study of 100 male and female PCS rats and sham-operated controls four to six weeks after the shunting procedure in an open field. The frequency, duration and average time sequence of various kinds of defined spontaneous behavioral patterns were investigated during both night and day in order to assess behavioral differences between PCS rats and sham-operated controls. The results indicate differences especially regarding motor exploratory behaviors such as forward locomotion and rearing. There were also differences in eating and sniffing behaviors. Our results show that the overall behavioral alteration seen in PCS rats compared to sham-operated controls is that of hypoactivity.

Entities:  

Mesh:

Year:  1997        PMID: 9101537     DOI: 10.1007/bf02676353

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  26 in total

1.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

2.  Problems with animal models of chronic liver disease: suggestions for improvement in standardization.

Authors:  K D Mullen; A J McCullough
Journal:  Hepatology       Date:  1989-03       Impact factor: 17.425

3.  The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.

Authors:  N Gitlin; D C Lewis; L Hinkley
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

4.  Spontaneous motor activity increases after portacaval anastomosis in rats.

Authors:  A Campbell; B Jeppsson; J H James; V Ziparo; J E Fischer
Journal:  Pharmacol Biochem Behav       Date:  1984-06       Impact factor: 3.533

5.  Maze patrolling, open-field behavior and runway activity following experimental portacaval anastomosis in rats.

Authors:  J R Martin; K Baettig; J Bircher
Journal:  Physiol Behav       Date:  1980-11

6.  Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat.

Authors:  M Bergeron; M S Swain; T A Reader; L Grondin; R F Butterworth
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

Review 7.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

8.  Postoperative course after portacaval anastomosis in rats is determined by the portacaval pressure gradient.

Authors:  D L Coy; A Srivastava; J Gottstein; R F Butterworth; A T Blei
Journal:  Am J Physiol       Date:  1991-12

9.  Brain monoamine metabolism and behavior in portacaval-shunted rats.

Authors:  F Bengtsson; F H Gage; B Jeppsson; A Nobin; E Rosengren
Journal:  Exp Neurol       Date:  1985-10       Impact factor: 5.330

10.  The impact of time after portacaval shunt in the rat on behavior, brain serotonin, and brain and muscle histology.

Authors:  F Bengtsson; M Bugge; A Brun; B Falck; K G Henriksson; A Nobin
Journal:  J Neurol Sci       Date:  1988-01       Impact factor: 3.181

View more
  1 in total

Review 1.  Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.

Authors:  Vicente Felipo
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.